<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Avances en SIDA : 1995</title>
  </titleInfo>
  <name type="personal">
    <namePart>Nájera Morrondo, Rafael</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>González Lahoz, J.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sp</placeTerm>
    </place>
    <dateIssued encoding="marc">1996</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
  </language>
  <physicalDescription>
    <extent>189 páginas</extent>
  </physicalDescription>
  <note>Editoriales y revisiones de la Publicación Oficial de la Sociedad Española Intedisciplinaria del SIDA</note>
  <subject>
    <topic>Sida</topic>
  </subject>
  <subject>
    <topic>Sindrome de Inmunodeficiencia Adquirida</topic>
  </subject>
  <subject>
    <topic>Vih</topic>
  </subject>
  <subject>
    <topic>Vacunas Contra Sida</topic>
  </subject>
  <subject>
    <topic>Tuberculosis</topic>
  </subject>
  <subject>
    <topic>España</topic>
  </subject>
  <subject>
    <topic>Seropositividad para Vih</topic>
  </subject>
  <subject>
    <topic>Sexualidad</topic>
  </subject>
  <subject>
    <topic>Transmision</topic>
  </subject>
  <subject>
    <topic>Medicina Legal</topic>
  </subject>
  <subject>
    <topic>Seguridad en el Trabajo</topic>
  </subject>
  <subject>
    <topic>Epidemiologia Molecular</topic>
  </subject>
  <subject>
    <topic>Vih-2</topic>
  </subject>
  <subject>
    <topic>Aspecto Psicosociales</topic>
  </subject>
  <subject>
    <topic>Terapia Antirretroviral Altamente Activa</topic>
  </subject>
  <subject>
    <topic>Vih-1</topic>
  </subject>
  <subject>
    <topic>Medicina Preventiva</topic>
  </subject>
  <subject>
    <topic>Prevencion de Accidentes</topic>
  </subject>
  <subject>
    <topic>Sistema Inmunologico</topic>
  </subject>
  <subject>
    <topic>Radicales Libres</topic>
  </subject>
  <subject>
    <topic>Plasma Rico en Plaquietas</topic>
  </subject>
  <subject>
    <topic>Europa</topic>
  </subject>
  <subject>
    <topic>Leishmaniasis</topic>
  </subject>
  <subject>
    <topic>Farmacología</topic>
  </subject>
  <subject>
    <topic>Infecciones por Citomegalovirus</topic>
  </subject>
  <subject>
    <topic>Vigilancia Epidemiologica</topic>
  </subject>
  <identifier type="isbn">84-7982-070-5</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">AR-ReUNN</recordContentSource>
    <recordCreationDate encoding="marc">260701</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260702161816.0</recordChangeDate>
    <recordIdentifier source="AR-ReUNN">295023</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
